In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of ProKidney Corp (NASDAQ: PROK) closed at $2.16 in the last session, down -4.00% from day before closing price of $2.25. In other words, the price has decreased by -$4.00 from its previous closing price. On the day, 2.18 million shares were traded. PROK stock price reached its highest trading level at $2.26 during the session, while it also had its lowest trading level at $2.14.
Ratios:
We take a closer look at PROK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.48 and its Current Ratio is at 11.48.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 08 ’25 when Weber Darin J. sold 103,480 shares for $3.02 per share. The transaction valued at 312,510 led to the insider holds 0 shares of the business.
DARIN J WEBER bought 103,480 shares of PROK for $62,761 on Jul 08 ’25. On Apr 22 ’25, another insider, Control Empresarial de Capital, who serves as the Add’l Rep. Persons-see Ex.99-1 of the company, bought 387,393 shares for $0.71 each. As a result, the insider paid 276,366 and bolstered with 73,842,723 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PROK now has a Market Capitalization of 1807641344 and an Enterprise Value of 1343229056. For the stock, the TTM Price-to-Sale (P/S) ratio is 1199.35. Its current Enterprise Value per Revenue stands at 2548.822 whereas that against EBITDA is -7.892.
Stock Price History:
The Beta on a monthly basis for PROK is 1.79, which has changed by -0.10373443 over the last 52 weeks, in comparison to a change of 0.18189907 over the same period for the S&P500. Over the past 52 weeks, PROK has reached a high of $7.13, while it has fallen to a 52-week low of $0.46. The 50-Day Moving Average of the stock is -17.25%, while the 200-Day Moving Average is calculated to be 36.99%.
Shares Statistics:
According to the various share statistics, PROK traded on average about 13.43M shares per day over the past 3-months and 1357680 shares per day over the past 10 days. A total of 133.42M shares are outstanding, with a floating share count of 99.34M. Insiders hold about 26.41% of the company’s shares, while institutions hold 30.46% stake in the company. Shares short for PROK as of 1755216000 were 8691695 with a Short Ratio of 0.65, compared to 1752537600 on 11412365. Therefore, it implies a Short% of Shares Outstanding of 8691695 and a Short% of Float of 9.020001.
Earnings Estimates
The stock of ProKidney Corp (PROK) is currently being evaluated by 5.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.09 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$0.44 and -$0.63 for the fiscal current year, implying an average EPS of -$0.53. EPS for the following year is -$0.57, with 6.0 analysts recommending between -$0.38 and -$0.75.
Revenue Estimates
For the next quarter, 4 analysts are estimating revenue of -$32.5k. There is a high estimate of $100k for the next quarter, whereas the lowest estimate is -$230k.